217 related articles for article (PubMed ID: 2624603)
1. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
Ishii A
Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
[TBL] [Abstract][Full Text] [Related]
2. Binding properties of (+/-)[3H]benidipine hydrochloride to rat heart membranes.
Ishii A; Toyama J
J Cardiovasc Pharmacol; 1993 Feb; 21(2):191-6. PubMed ID: 7679151
[TBL] [Abstract][Full Text] [Related]
3. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites.
Ishii A; Nishida K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140
[TBL] [Abstract][Full Text] [Related]
4. Receptor binding properties of the new calcium antagonist benidipine hydrochloride.
Ishii A; Nishida K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1677-80. PubMed ID: 2851301
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
6. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
[TBL] [Abstract][Full Text] [Related]
7. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
8. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
Bellemann P; Ferry D; Lübbecke F; Glossmann H
Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
[TBL] [Abstract][Full Text] [Related]
9. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
10. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Gould RJ; Murphy KM; Snyder SH
Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
[TBL] [Abstract][Full Text] [Related]
11. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
12. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
13. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
Bellemann P; Ferry D; Lübbecke F; Glossman H
Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
[TBL] [Abstract][Full Text] [Related]
14. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma.
Miwa N; Kanaide H; Nishimura J; Nakamura M
Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey.
Nakajima M; Adachi I; Ueda M
Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of [3H]nitrendipine binding sites in rat spinal cord.
Gandhi VC; Jones DJ
J Pharmacol Exp Ther; 1988 Nov; 247(2):473-80. PubMed ID: 2460614
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
18. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Mihara S; Fujimoto M
Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
20. Sensitive radioreceptor assay of the calcium antagonist benidipine hydrochloride in plasma and urine.
Ishii A; Nishida K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1733-7. PubMed ID: 3219150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]